NVCR NovoCure Ltd NASDAQ · United States

NovoCure (NVCR) news

NovoCure Ltd is a public biotech or pharmaceutical company listed on NASDAQ under the ticker NVCR, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest NovoCure news

We have not published a story on NovoCure yet. When there is news, it will appear here.

NovoCure annual financials

Line	FY2025	FY2024
Revenue	$655.4 million	$605.2 million
Research and development	$224.5 million	$209.6 million
Net income (loss)	-$136.2 million	-$168.6 million
Cash from operations	-$49.0 million	-$26.4 million
Cash and equivalents	$93.5 million	$163.8 million

Latest balance sheet, Sep 30, 2026 (10-Q): cash and equivalents $96.7 million.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

Questions about NovoCure

What is the ticker symbol of NovoCure?

NovoCure Ltd trades under the ticker NVCR on NASDAQ.

Where is NovoCure listed?

NovoCure Ltd is listed on NASDAQ.

Which country or territory is NovoCure listed under?

Our directory records NovoCure Ltd under United States.

Does aibio.space cover NovoCure?

aibio.space lists NovoCure Ltd among 2,820 public biotech companies and publishes its news here as stories appear.

What was NovoCure's revenue last year?

$655.4 million for the fiscal year ended Dec 31, 2025, as reported to the SEC.

Is NovoCure profitable?

NovoCure Ltd reported a net loss of $136.2 million for the fiscal year ended Dec 31, 2025, and used $49.0 million of cash in operations, per its annual report to the SEC.

How much does NovoCure spend on research and development?

$224.5 million in the fiscal year ended Dec 31, 2025, per its annual report.

How much cash does NovoCure have?

$96.7 million in cash at Sep 30, 2026, per its 10-Q.

Investor discussion: NovoCure

Members talk about NovoCure (NVCR). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NASDAQ:NVCR on TradingView.

Listing details

Company: NovoCure Ltd
Ticker: NVCR
Listing: NASDAQ
Country or territory: United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction